This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Commissariat a L'energie Atomique Et Aux Energies Alternatives. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: Vincent Beringue: Innovator in Therapeutic Screening Methods
Introduction
Vincent Beringue is a notable inventor based in Thiverval Grignon, France. He has made significant contributions to the field of medical research, particularly in the area of transmissible subacute spongiform encephalopathies (TSSE) and prion diseases. His innovative approach to screening substances with therapeutic action has the potential to impact treatment methodologies significantly.
Latest Patents
Vincent Beringue holds a patent for a method designed to screen substances capable of having therapeutic action in the treatment of TSSE. This patent outlines a process that includes isolating PrPres from the spleen, along with methods specifically adapted for this screening. The applications of this invention are particularly relevant for detecting PrPres, which is crucial in understanding and treating prion diseases.
Career Highlights
Beringue is affiliated with the Commissariat à l'Énergie Atomique, where he has been able to apply his research and innovations in a practical setting. His work has garnered attention for its potential to advance therapeutic options for serious neurological conditions.
Collaborations
Vincent Beringue has collaborated with esteemed colleagues such as Jean-Philippe Deslys and Corinne Lasmezas. These partnerships have likely enriched his research and contributed to the development of his patented methods.
Conclusion
Vincent Beringue's contributions to the field of therapeutic screening for prion diseases highlight his role as an innovator in medical research. His work not only advances scientific understanding but also opens new avenues for treatment.